New drug trial offers hope for COPD patients
Disease control
Not yet recruiting
This study is testing whether a new medication called Hemay005 can help control moderate-to-severe COPD. About 120 adults with COPD will take either Hemay005, a placebo (inactive pill), or an existing COPD medication for 12 weeks. Researchers will measure changes in lung inflamma…
Phase: PHASE2 • Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC